Cargando…

Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline

Detalles Bibliográficos
Autores principales:	Bussian, Tyler J., Aziz, Asef, Meyer, Charlton F., Swenson, Barbara L., van Deursen, Jan M., Baker, Darren J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206507/ https://www.ncbi.nlm.nih.gov/pubmed/30232451 http://dx.doi.org/10.1038/s41586-018-0543-y

Ejemplares similares

Glial Tau Pathology in Tauopathies: Functional Consequences
por: Kahlson, Martha A., et al.
Publicado: (2016)

Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in physiology and pathology
por: DeFelipe, Javier
Publicado: (2016)

Human tau pathology transmits glial tau aggregates in the absence of neuronal tau
por: Narasimhan, Sneha, et al.
Publicado: (2019)

Hearing impairment is associated with cognitive decline, brain atrophy and tau pathology
por: Wang, Hui-Fu, et al.
Publicado: (2022)

Oncogenic senescence: a multi-functional perspective
por: Baker, Darren J., et al.
Publicado: (2017)

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
por: Bryant, Annie G., et al.
Publicado: (2020)

Glial phagocytic clearance in Parkinson’s disease
por: Tremblay, Marie-Eve, et al.
Publicado: (2019)

Tau immunotherapy is associated with glial responses in FTLD-tau
por: Kim, Boram, et al.
Publicado: (2021)

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
por: Cicognola, Claudia, et al.
Publicado: (2018)

Tau pathology epigenetically remodels the neuron-glial cross-talk in Alzheimer’s disease
por: Zhou, Lan-Ting, et al.
Publicado: (2023)

Chemotherapy-induced cellular senescence suppresses progression of Notch-driven T-ALL
por: Zhang, Ying, et al.
Publicado: (2019)

Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum
por: Chen, Yi-He, et al.
Publicado: (2022)

Tau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity
por: Koller, Emily J., et al.
Publicado: (2020)

Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits
por: Noël, Anastasia, et al.
Publicado: (2021)

Plasma phosphorylated tau181 predicts cognitive and functional decline
por: Tropea, Thomas F., et al.
Publicado: (2022)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
por: Ossenkoppele, Rik, et al.
Publicado: (2022)

Mechanisms of Aβ Clearance and Degradation by Glial Cells
por: Ries, Miriam, et al.
Publicado: (2016)

An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer’s disease
por: Lau, Victor, et al.
Publicado: (2023)

Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases
por: Biechele, Gloria, et al.
Publicado: (2020)

Effect of peripheral cellular senescence on brain aging and cognitive decline
por: Budamagunta, Vivekananda, et al.
Publicado: (2023)

Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults
por: Pereira, Joana B., et al.
Publicado: (2020)

Role of tau deposition in early cognitive decline in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Glial decline and loss of homeostatic support rather than inflammation defines cognitive aging
por: Verkhratsky, Alexei, et al.
Publicado: (2021)

Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau
por: McCollum, Lauren E., et al.
Publicado: (2021)

Expanding the phenotypic associations of globular glial tau subtypes
por: Burrell, James R., et al.
Publicado: (2016)

Astrocyte senescence may drive alterations in GFAPα, CDKN2A p14(ARF), and TAU3 transcript expression and contribute to cognitive decline
por: Lye, Jed J., et al.
Publicado: (2019)

Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease‐related declines
por: Thomas, Kelsey R., et al.
Publicado: (2021)

Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint
por: Thomas, Kelsey R., et al.
Publicado: (2022)

Tau pathology in cognitively normal older adults
por: Ziontz, Jacob, et al.
Publicado: (2019)

Maternal Resveratrol Supplementation Prevents Cognitive Decline in Senescent Mice Offspring
por: Izquierdo, Vanesa, et al.
Publicado: (2019)

Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
por: Hall, James R., et al.
Publicado: (2021)

Microglial activation and tau burden predict cognitive decline in Alzheimer’s disease
por: Malpetti, Maura, et al.
Publicado: (2020)

Medial temporal tau predicts memory decline in cognitively unimpaired elderly
por: Kwan, Angela T H, et al.
Publicado: (2022)

Impaired peri-olfactory cerebrospinal fluid clearance is associated with ageing, cognitive decline and dyssomnia
por: Zhou, Ying, et al.
Publicado: (2022)

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome
por: Grigorova, Monika, et al.
Publicado: (2022)

CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy
por: Joly-Amado, Aurelie, et al.
Publicado: (2020)

Tau exhibits unique seeding properties in globular glial tauopathy
por: Chung, Dah-eun Chloe, et al.
Publicado: (2019)

ARF: Connecting senescence and innate immunity for clearance
por: Kearney, Alper Y., et al.
Publicado: (2015)

The Fate of Tau Aggregates Between Clearance and Transmission
por: Seitkazina, Assel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_76n2kscaaq1pjau92rgblhkrcc